SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
EPS Diluted Over TimeContracting
Percentile Rank67
Studio
Year-over-Year Change

Diluted earnings per share

Percentile
P67
Within normal range
vs 5Y Ago
-0.4x
Contraction
Streak
2 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM-2.67+27.4%
2024-3.68+51.8%
2023-7.64-77.3%
2022-4.31+31.6%
2021-6.30-184.6%
20207.45+3486.4%
2019-0.22-